Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover Trial
Latest Information Update: 26 Apr 2024
At a glance
- Drugs Alirocumab (Primary) ; Bempedoic acid (Primary) ; Evolocumab (Primary) ; Ezetimibe (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms BESAFE
- 26 Apr 2024 New trial record